Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Yes, both recent viral infections and certain medications are among the most common causes of leukopenia, a low white blood cell count. Viruses such as influenza, COVID-19, Epstein-Barr, hepatitis, and HIV can temporarily suppress bone marrow production or increase white cell destruction, and counts often recover within days to weeks after the illness clears. Medications including chemotherapy agents, antibiotics, antithyroid drugs, anticonvulsants, immunosuppressants, and some antipsychotics can also lower white cells, sometimes sharply. Other explanations, such as autoimmune disease, nutrient deficiencies, or bone marrow disorders, may also be responsible, and the timing, severity, and pattern of your results matter greatly. There are several important factors to consider before assuming the cause is harmless, so review the complete details below.
If you are trying to make sense of a low white blood cell count, guessing between a passing virus and a drug side effect can delay care that matters, especially if fever, mouth sores, or repeated infections appear. A free, instant online symptom check lets you enter your symptoms, recent illnesses, and medications in a few minutes and receive tailored information on likely causes and which specialist to see. It costs nothing, requires no appointment, and gives you clear language to bring to your doctor so your next visit is faster and more focused. Taking a few minutes now can help you decide whether to monitor at home or seek prompt evaluation.
Last reviewed for medical accuracy: 09/17/2026
Can a Recent Virus or My Medication Cause Leukopenia?
Leukopenia is the medical term for a lower-than-normal white blood cell (WBC) count. White blood cells are a crucial part of your immune system, helping your body fight off infections. When your WBC count drops, you may be more prone to infections and have a harder time recovering from them. It’s natural to wonder whether a recent viral infection or a medication you’re taking could be behind a low white blood cell count. Below, we explore the role of viruses and medications in causing leukopenia, how it’s diagnosed, and when to seek further medical advice.
Leukopenia refers to a decrease in the total number of white blood cells (leukocytes) circulating in your blood. A standard complete blood count (CBC) flags leukopenia when your WBC falls below the lab’s reference range (often fewer than 4,000–4,500 cells per microliter, depending on the lab). There are several types of white blood cells, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. A drop in neutrophils (neutropenia) is one specific type of leukopenia that is especially important, because neutrophils are the body’s first line of defense against bacterial infections.
Viral infections are a common cause of transient leukopenia. Here’s how they can affect your white blood cell count:
Most viral causes of leukopenia are self-limited, meaning your white blood cell count will often rebound as you recover. However, this rebound can take days to weeks.
Many commonly prescribed drugs have leukopenia as a known side effect. They can act by:
If you’ve recently started a new medication and your bloodwork shows leukopenia, it’s important to discuss with your prescribing doctor whether that drug could be the culprit. In many cases, adjusting the dose or switching to an alternative therapy can resolve the issue.
Leukopenia itself may not cause obvious symptoms, but the reduced immunity can lead to:
If you notice any of these signs, or if you have a confirmed low WBC count on a routine blood test, further evaluation is warranted.
Tip: You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance and help decide when to see a clinician.
To pinpoint why your WBC count is low, your healthcare provider may recommend:
Together, these steps help distinguish between transient, self-limited causes and those requiring targeted treatment.
If a viral infection is the likely cause, management typically focuses on supportive care:
In most healthy adults, white blood cell counts recover within one to three weeks following the acute phase of the viral illness.
If a drug you’re taking is responsible, your doctor may recommend:
Never stop or change prescribed medications without your healthcare provider’s guidance.
While mild leukopenia often resolves on its own or with minor treatment adjustments, certain situations require immediate medical attention:
If you experience any of these, call your healthcare provider right away or go to the nearest emergency department.
Most patients with leukopenia caused by a viral infection or a reversible medication side effect recover fully. Chronic leukopenia—lasting more than a few weeks—may require additional workup for:
Your long-term care plan will depend on the underlying cause and may involve specialists such as hematologists or infectious disease experts.
Always remember: if you’re unsure about your symptoms or blood test results, it’s best to consult a medical professional. Your health is too important to leave to chance—speak to a doctor about any serious or life-threatening concerns.
(References)
* Parrish CR. Pathogenesis of feline panleukopenia virus and canine parvovirus. Baillieres Clin Haematol. 1995 Mar;8(1):57-71. doi: 10.1016/s0950-3536(05)80232-x. PMID: 7663051; PMCID: PMC7134857.
* Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis. 2009 May 15;199(10):1435-41. doi: 10.1086/598684. PMID: 19392620.
* Ohta M, Taga T, Nomura A, Kato H, Takano T, Maruo Y, Takeuchi Y, Ishida M, Ohta S. Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma. J Med Virol. 2011 Sep;83(9):1582-4. doi: 10.1002/jmv.22136. PMID: 21739449.
* Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678. PMID: 32353870; PMCID: PMC7191310.
* Sul H, Yun NR, Kim DM, Kim YK, Kim J, Hur J, Jung SI, Ryu SY, Lee JY, Huh K, Kwak YG, Jeong HW, Heo JY, Jung DS, Lee SH, Park SH, Yeom JS, Lee H. Development of a Scoring System to Differentiate Severe Fever with Thrombocytopenia Syndrome from Scrub Typhus. Viruses. 2022 May 19;14(5). doi: 10.3390/v14051093. Epub 2022 May 19. PMID: 35632834; PMCID: PMC9143636.
* Nakada N, Yamamoto K, Tanaka M, Ashizawa H, Yoshida M, Umemura A, Fukuda Y, Katoh S, Sumiyoshi M, Mihara S, Kobayashi T, Ito Y, Ashizawa N, Takeda K, Ide S, Iwanaga N, Takazono T, Tashiro M, Tanaka T, Nakamichi S, Morimoto K, Ariyoshi K, Morita K, Kurihara S, Yanagihara K, Furumoto A, Izumikawa K, Mukae H. Clinical Differentiation of Severe Fever with Thrombocytopenia Syndrome from Japanese Spotted Fever. Viruses. 2022 Aug 18;14(8). doi: 10.3390/v14081807. Epub 2022 Aug 18. PMID: 36016429; PMCID: PMC9415593.
* Reischig T, Vlas T, Kacer M, Pivovarcikova K, Lysak D, Nemcova J, Drenko P, Machova J, Bouda M, Sedivcova M, Kormunda S. A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients. J Am Soc Nephrol. 2023 May 1;34(5):920-934. doi: 10.1681/ASN.0000000000000090. Epub 2023 Feb 2. PMID: 36749127; PMCID: PMC10125645.
* Hatzl S, Posch F, Linhofer M, Aberle S, Zollner-Schwetz I, Krammer F, Krause R. Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea. Emerg Infect Dis. 2023 May;29(5):1038-1041. doi: 10.3201/eid2905.221625. PMID: 37081597; PMCID: PMC10124650.
* Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA. 2023 Jul 3;330(1):33-42. doi: 10.1001/jama.2023.9106. PMID: 37279999; PMCID: PMC10245286.
* Shankar-Hari M, Francois B, Remy KE, Gutierrez C, Pastores S, Daix T, Jeannet R, Blood J, Walton AH, Salomao R, Auzinger G, Striker D, Martin RS, Anand NJ, Bosanquet J, Blood T, Brakenridge S, Moldawer LL, Vachharajani V, Yee C, Dal-Pizzol F, Morre M, Berbille F, van den Brink M, Hotchkiss R. A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19. JCI Insight. 2025 Feb 4;10(6). doi: 10.1172/jci.insight.189150. Epub 2025 Feb 4. PMID: 39903535; PMCID: PMC11949036.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.